세계의 수면장애 치료 시장 규모 조사 및 예측, 약제 유형별, 용도별, 지역별 분석(2022-2029년)

Global Sleep Disorders Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The sleep disorders treatment market refers to the industry that develops, produces, and markets various products and services that are used to diagnose and treat sleep disorders such as insomnia, sleep apnea, restless leg syndrome, and others. The market includes pharmaceutical drugs, medical devices, and behavioral therapies. The major driving factors for the Global Sleep Disorders Treatment Market are increasing prevalence of sleep disorders, growing aging population and increasing awareness about sleep disorders. Moreover, advancements in treatment options and favorable reimbursement policies of government are creating lucrative growth opportunity for the market over the forecast period 2022-2029.

The rising incidence of sleep disorders and the general increase in public knowledge of these conditions are factors in the market's expansion. Half of US adults report having insomnia once a month or more, according to Helsestart data on world insomnia numbers in 2022 and 2023. The West is the region most susceptible to insomnia, with about 59% of adults experiencing insomnia at some time. The same source also claimed that, among all nations, individuals in Japan, Taiwan, and Sweden struggle with insomnia the most. In the two years between 2021 and 2022, Norway had 67 more melatonin inquiries per 100,000 people than Sweden, making it the country with the most melatonin searches globally. However, the high cost of Sleep Disorders Treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Sleep Disorders Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the largest market for sleep disorders treatment due to the high prevalence of sleep disorders, favorable reimbursement policies, and the presence of major players in the region. The Asia-Pacific region is expected to witness significant growth in the sleep disorders treatment market due to the rising prevalence of sleep disorders, increasing healthcare expenditure, and the presence of a large patient pool.

Major market players included in this report are:

• Takeda Pharmaceuticals USA Inc.
• Vanda Pharmaceuticals Inc.
• Merck & Co.
• Mylan NV
• Pfizer
• Teva Pharmaceuticals USA Inc
• Philips Healthcare
• ResMed
• Fisher & Paykel Healthcare
• GlaxoSmithKline

Recent Developments in the Market:

• In 2021, Philips launched its DreamStation 2, a continuous positive airway pressure (CPAP) device for sleep apnea treatment. The device is designed to be smaller and quieter than its predecessor, making it more comfortable for patients to use.
• In 2021, ResMed acquired a digital therapeutics company, Propeller Health, to expand its offerings in respiratory and sleep therapy. Propeller Health's platform uses sensors and software to help patients manage their respiratory conditions.

Global Sleep Disorders Treatment Market Report Scope:

• Historical Data: 2019-2020-2021
• Base Year for Estimation: 2021
• Forecast period: 2022-2029
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Drug Type, Application, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Drug Type offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Type:

• Benzodiazepines
• Nonbenzodiazepines
• Antidepressants
• Other Drug Types

By Application:

• Insomnia
• Sleep Apnea
• Narcolepsy
• Circadian disorders
• Other Applications

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Sleep Disorders Treatment Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Sleep Disorders Treatment Market, by Drug Type, 2019-2029 (USD Billion)
  • 1.2.3. Sleep Disorders Treatment Market, by Application, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Sleep Disorders Treatment Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Sleep Disorders Treatment Market Dynamics

• 3.1. Sleep Disorders Treatment Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing prevalence of sleep disorders
    • 3.1.1.2. Growing Geriatric Population
    • 3.1.1.3. Increasing awareness about sleep disorders
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Sleep Disorders Treatment
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Advancements in treatment options
    • 3.1.3.2. Favorable reimbursement policies by government

Chapter 4. Global Sleep Disorders Treatment Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Sleep Disorders Treatment Market, by Drug Type

• 6.1. Market Snapshot
• 6.2. Global Sleep Disorders Treatment Market by Drug Type, Performance - Potential Analysis
• 6.3. Global Sleep Disorders Treatment Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
• 6.4. Sleep Disorders Treatment Market, Sub Segment Analysis
  • 6.4.1. Benzodiazepines
  • 6.4.2. Nonbenzodiazepines
  • 6.4.3. Antidepressants
  • 6.4.4. Other Drug Types

Chapter 7. Global Sleep Disorders Treatment Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Sleep Disorders Treatment Market by Application, Performance - Potential Analysis
• 7.3. Global Sleep Disorders Treatment Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
• 7.4. Sleep Disorders Treatment Market, Sub Segment Analysis
  • 7.4.1. Insomnia
  • 7.4.2. Sleep Apnea
  • 7.4.3. Narcolepsy
  • 7.4.4. Circadian disorders
  • 7.4.5. Other Applications

Chapter 8. Global Sleep Disorders Treatment Market, Regional Analysis

• 8.1. Sleep Disorders Treatment Market, Regional Market Snapshot
• 8.2. North America Sleep Disorders Treatment Market
  • 8.2.1. U.S. Sleep Disorders Treatment Market
    • 8.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Sleep Disorders Treatment Market
• 8.3. Europe Sleep Disorders Treatment Market Snapshot
  • 8.3.1. U.K. Sleep Disorders Treatment Market
  • 8.3.2. Germany Sleep Disorders Treatment Market
  • 8.3.3. France Sleep Disorders Treatment Market
  • 8.3.4. Spain Sleep Disorders Treatment Market
  • 8.3.5. Italy Sleep Disorders Treatment Market
  • 8.3.6. Rest of Europe Sleep Disorders Treatment Market
• 8.4. Asia-Pacific Sleep Disorders Treatment Market Snapshot
  • 8.4.1. China Sleep Disorders Treatment Market
  • 8.4.2. India Sleep Disorders Treatment Market
  • 8.4.3. Japan Sleep Disorders Treatment Market
  • 8.4.4. Australia Sleep Disorders Treatment Market
  • 8.4.5. South Korea Sleep Disorders Treatment Market
  • 8.4.6. Rest of Asia Pacific Sleep Disorders Treatment Market
• 8.5. Latin America Sleep Disorders Treatment Market Snapshot
  • 8.5.1. Brazil Sleep Disorders Treatment Market
  • 8.5.2. Mexico Sleep Disorders Treatment Market
• 8.6. Rest of The World Sleep Disorders Treatment Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Takeda Pharmaceuticals USA Inc.
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Vanda Pharmaceuticals Inc.
  • 9.2.3. Merck & Co.
  • 9.2.4. Mylan NV
  • 9.2.5. Pfizer
  • 9.2.6. Teva Pharmaceuticals USA Inc
  • 9.2.7. Philips Healthcare
  • 9.2.8. ResMed
  • 9.2.9. Fisher & Paykel Healthcare
  • 9.2.10. GlaxoSmithKline

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption